SGD alleviates Helicobacter pylori-induced chronic atrophic gastritis (CAG) by inhibiting MAOB (Li Z. et al., 2024), and Helicobacter pylori plays an important role in CAG. This evidence concerns the gene MAOB and chronic atrophic gastritis.